Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Ancillary Services & Strategic Initiatives | | | | | | | 1,621.4 | 1,382.4 |
| U.S. Dialysis & Related Lab Services | | | | | | | 9,551.4 | 8,641.4 |
| Total revenues [+] | 11,609.9 | 11,618.8 | 11,550.6 | 11,388.5 | 11,404.9 | 10,876.6 | 10,707.5 | 9,982.2 |
| Healthcare | | | | | | | | 9,155.4 |
| Other income | 433.4 | 405.3 | 524.4 | 491.8 | 744.5 | 1,268.3 | 1,411.4 | |
| Revenue growth [+] | -0.1% | 0.6% | 1.4% | -0.1% | 4.9% | 1.6% | 7.3% | -22.0% |
| Ancillary Services & Strategic Initiatives | | | | | | | 17.3% | 21.3% |
| U.S. Dialysis & Related Lab Services | | | | | | | 10.5% | 5.2% |
| Cost of goods sold | 8,209.6 | 7,972.4 | 8,004.9 | 7,914.5 | 8,149.4 | 7,930.6 | 7,083.9 | 6,865.3 |
| Gross profit | 3,400.3 | 3,646.4 | 3,545.7 | 3,474.0 | 3,255.4 | 2,946.1 | 3,623.6 | 3,116.9 |
| Gross margin | 29.3% | 31.4% | 30.7% | 30.5% | 28.5% | 27.1% | 33.8% | 31.2% |
| Selling, general and administrative [+] | 1,355.2 | 1,195.3 | 1,247.6 | 1,103.3 | 1,135.5 | 1,064.0 | 1,072.8 | 1,031.1 |
| General and administrative | 1,355.2 | 1,195.3 | 1,247.6 | 1,103.3 | 1,135.5 | 1,064.0 | 1,072.8 | 1,031.1 |
| Equity in earnings | -26.5 | -26.9 | -26.9 | -12.7 | 4.5 | 8.6 | -16.9 | -13.9 |
| Other operating expenses | -26.5 | -26.9 | -43.2 | -12.7 | 60.6 | 6.3 | 357.5 | -13.9 |
| EBITDA [+] | 2,071.7 | 2,478.0 | 2,341.3 | 2,383.4 | 2,063.8 | 2,102.0 | 2,404.0 | 2,273.9 |
| EBITDA growth | -16.4% | 5.8% | -1.8% | 15.5% | -1.8% | -12.6% | 5.7% | -6.2% |
| EBITDA margin | 17.8% | 21.3% | 20.3% | 20.9% | 18.1% | 19.3% | 22.5% | 22.8% |
| Depreciation | 721.1 | 667.8 | 616.6 | 600.9 | 574.8 | 761.7 | 705.7 | 618.8 |
| EBITA | 1,350.5 | 1,810.2 | 1,724.7 | 1,782.5 | 1,489.0 | 1,340.3 | 1,698.3 | 1,655.0 |
| EBITA margin | 11.6% | 15.6% | 14.9% | 15.7% | 13.1% | 12.3% | 15.9% | 16.6% |
| Amortization of intangibles | 11.5 | 12.9 | 13.8 | 14.2 | 16.2 | 15.8 | 14.6 | 19.2 |
| EBIT [+] | 1,339.1 | 1,797.4 | 1,710.9 | 1,768.2 | 1,472.8 | 1,324.5 | 1,683.8 | 1,635.8 |
| EBIT growth | -25.5% | 5.1% | -3.2% | 20.1% | 11.2% | -21.3% | 2.9% | -10.7% |
| EBIT margin | 11.5% | 15.5% | 14.8% | 15.5% | 12.9% | 12.2% | 15.7% | 16.4% |
| Non-recurring items [+] | | | 16.3 | 124.9 | -57.5 | -496.9 | -346.0 | 499.1 |
| Asset impairment | | | | 124.9 | 3.1 | 36.2 | 28.4 | 4.1 |
| Loss (gain) on sale of business | | | 16.3 | | -60.6 | -6.3 | -374.4 | |
| Legal settlement | | | | | | -526.8 | | 495.0 |
| Interest expense | 357.0 | 285.3 | 304.1 | 443.8 | 487.4 | 430.6 | 414.1 | 408.4 |
| Interest expense | 357.0 | 285.3 | 304.1 | 443.8 | 487.4 | 430.6 | 414.1 | 408.4 |
| Other income (expense), net [+] | -15.8 | 6.4 | -72.3 | -4.1 | 5.6 | 9.0 | 7.5 | -40.0 |
| Asset impairment charges | | | | | 17.3 | 295.2 | 15.0 | |
| Extraordinary gain | | | | | 28.2 | | | |
| Other | -15.8 | 6.4 | 16.8 | 29.3 | 10.1 | 17.7 | 7.5 | 8.1 |
| Pre-tax income | 966.3 | 1,518.5 | 1,318.3 | 1,195.4 | 1,048.5 | 1,399.8 | 1,623.1 | 688.4 |
| Income taxes | 198.1 | 306.7 | 313.9 | 279.6 | 258.4 | 323.9 | 431.8 | 207.5 |
| Tax rate | 20.5% | 20.2% | 23.8% | 23.4% | 24.6% | 23.1% | 26.6% | 30.1% |
| Minority interest | 221.2 | 233.3 | 221.0 | 210.3 | 173.6 | 166.9 | 153.2 | 157.7 |
| Earnings from continuing ops | 546.9 | 978.5 | 1,787.6 | 705.5 | 1,406.5 | 1,984.9 | 2,229.5 | 804.1 |
| Earnings from discontinued ops | 13.5 | | -9.7 | 105.5 | -457.0 | -245.4 | -158.3 | -53.5 |
| Net income | 560.4 | 978.5 | 1,778.0 | 811.0 | 949.5 | 1,739.5 | 2,071.2 | 750.6 |
| Net margin | 4.8% | 8.4% | 15.4% | 7.1% | 8.3% | 16.0% | 19.3% | 7.5% |
| |
| Basic EPS [+] | $5.88 | $9.30 | $14.92 | $4.61 | $8.24 | $10.52 | $11.06 | $3.80 |
| Growth | -36.7% | -37.7% | 224.0% | -44.1% | -21.7% | -4.8% | 191.3% | 11.4% |
| Diluted EPS [+] | $5.71 | $8.90 | $14.58 | $4.59 | $8.16 | $10.37 | $10.88 | $3.72 |
| Growth | -35.9% | -39.0% | 217.8% | -43.8% | -21.3% | -4.7% | 192.6% | 11.5% |
| |
| Shares outstanding (basic) [+] | 93.0 | 105.2 | 119.8 | 153.2 | 170.8 | 188.6 | 201.6 | 211.9 |
| Growth | -11.6% | -12.2% | -21.8% | -10.3% | -9.5% | -6.5% | -4.8% | -0.2% |
| Shares outstanding (diluted) [+] | 95.8 | 109.9 | 122.6 | 153.8 | 172.4 | 191.3 | 204.9 | 216.3 |
| Growth | -12.8% | -10.3% | -20.3% | -10.8% | -9.9% | -6.6% | -5.2% | -0.3% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|